Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-10 6:03 pm Purchase | 2025-10-24 | 13G | THERIVA BIOLOGICS, INC. TOVX | Jeffrey Matthew Gryga Irrevocable Trust | 739,211 7.700% | 739,211 (New Position) | Filing History |
| 2025-10-21 09:04 am Sale | 2025-09-30 | 13G | THERIVA BIOLOGICS, INC. TOVX | Empery Asset Management, LP | 504,091 4.990% | -449,094 (-47.12%) | Filing History |
| 2025-07-31 4:37 pm Purchase | 2025-06-30 | 13G | THERIVA BIOLOGICS, INC. TOVX | Empery Asset Management, LP | 953,185 9.990% | 238,899 (+33.45%) | Filing History |
| 2025-02-07 4:10 pm Sale | 2024-12-31 | 13G | THERIVA BIOLOGICS, INC. TOVX | CVI Investments, Inc. | 146,136 4.900% | -86,101 (-37.07%) | Filing History |
| 2024-10-03 4:12 pm Purchase | 2024-09-26 | 13G | THERIVA BIOLOGICS, INC. TOVX | Mitchell P. Kopin | 118,526 4.990% | 118,526 (New Position) | Filing History |
| 2024-10-02 10:53 am Purchase | 2024-09-27 | 13G | THERIVA BIOLOGICS, INC. TOVX | CVI Investments, Inc. | 232,237 9.900% | 232,237 (New Position) | Filing History |
| 2022-02-23 4:42 pm Sale | 2021-12-31 | 13G | SYNTHETIC BIOLOGICS INC SYN | Iroquois Capital Management, LLC | 230,870 1.920% | -30,000 (-11.50%) | Filing History |
| 2022-02-10 6:11 pm Sale | 2021-12-31 | 13G | SYNTHETIC BIOLOGICS INC NE SYN | RENAISSANCE TECHNOLOGIES LLC | 2,060 0.020% | -121,713 (-98.34%) | Filing History |
| 2022-02-04 4:23 pm Purchase | 2021-12-31 | 13G | SYNTHETIC BIOLOGICS INC NE SYN | Hudson Bay Capital Management LP | 260,870 1.940% | 38,968 (+17.56%) | Filing History |